During the past decade, Nephrology Associates, P.C. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 11 clinical trials were completed, i.e. on average, 275% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nephrology Associates, P.C." #1 sponsor was "Keryx Biopharmaceuticals" with 4 trials, followed by "Shire" with 4 trials sponsored, "Abbott" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nephrology Associates, P.C." #1 collaborator was "Abbott" with 1 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Collaborative Study Group (CSG)" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Nephrology Associates, P.C." are "Hyperphosphatemia" (4 trials), "Kidney Failure" (3 trials), "Chronic Kidney Disease (CKD)" (2 trials), "Diabetic Nephropathy" (2 trials) and "End-Stage Renal Disease" (2 trials). Many other conditions were trialed in "Nephrology Associates, P.C." in a lesser frequency.

Most popular intervention types in "Nephrology Associates, P.C." are "Drug" (18 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Lanthanum carbonate" (3 trials), "Participating Site's standard practice" (2 trials), "SRM003" (2 trials) and "ferric citrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nephrology Associates, P.C." are 21 trials for "All" genders.

Currently, there are NaN active trials in "Nephrology Associates, P.C.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Nephrology Associates, P.C., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nephrology Associates, P.C., 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".